UNIVERSITY OF ADELAIDE By restricting the time period during which they could eat, researchers have seen promising results for controlling blood glucose levels in men at risk of type 2 diabetes. In a small study now published in the journal Obesity, researchers from the University of Adelaide and the South Australian Health and Medical Research Institute...
Tag: <span>Diabetes</span>
Post
Drug reduces risk of kidney failure in people with diabetes, study finds
by Amy Jeter Hansen, Stanford University Medical Center A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease. “For the first time in 18 years, we have a therapy for patients with Type 2 diabetes and chronic kidney disease that decreases kidney failure,” said Kenneth Mahaffey, MD, professor...
Post
Three easy measures to predict metabolic syndrome in elderly
MARY ANN LIEBERT, INC./GENETIC ENGINEERING NEWS New Rochelle, NY, April 2, 2019–A new study found a surprisingly high rate of metabolic syndrome among individuals aged 60-100 years. Three easy-to-measure anthropometric indicators were predictive of metabolic syndrome in both men and women and could be useful for indicating the need for preventive care and further testing,...
Post
Lab-grown blood vessels provide hope for dialysis patients
By Kate Bass, B.Sc.Reviewed by Kate Anderton, B.Sc. Research published this week describes how lab-grown blood vessels were transformed into living tissue when grafted into dialysis patients needing replacement blood vessels. The recipients’ cells effectively infiltrated the artificial blood vessels, so they became like the patients’ native blood vessels. There are many conditions for which...
Post
A1c test misses many cases of diabetes
THE ENDOCRINE SOCIETY NEW ORLEANS–Using the hemoglobin A1c blood test to diagnose diabetes tends to underestimate the prevalence of the disease, according to a new study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La. “Based on our findings, A1c should not be solely used to determine the prevalence of diabetes,” said lead researcher Maria...
Post
Diabetes treatment may keep dementia, Alzheimer’s at bay
Study finds progression of dementia and Alzheimer’s signature tangles are much faster in people with untreated diabetes UNIVERSITY OF SOUTHERN CALIFORNIA Patients on medication for type 2 diabetes may be keeping Alzheimer’s disease away. USC Dornsife psychologists have found that those patients with untreated diabetes developed signs of Alzheimer’s disease 1.6 times faster than people...
Post
Gene transfer improves diabetes-linked heart ailment
VETERANS AFFAIRS RESEARCH COMMUNICATIONS Researchers with the VA San Diego Healthcare System and the University of California San Diego have shown that a gene transfer technique can combat heart dysfunction caused by diabetes. Working with mice, the researchers showed that a single injection to promote the expression of the hormone urocortin 2 (UCn2) increased left ventricle function and improved how...
Post
Testosterone discovery may explain low levels in men with diabetes
Scientists at the University of Virginia and elsewhere have mapped out how the body transports testosterone, and their surprising findings may explain low testosterone levels seen in men with diabetes or patients on certain medications. The discovery allows scientists to understand exactly how testosterone, the male sex hormone, binds to a protein called serum albumin...
Post
Older adults with type 1 diabetes often not aware of hypoglycemia
THE ENDOCRINE SOCIETY NEW ORLEANS–Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La. Those who are not aware their blood sugar is too low can spend more than 100 minutes a day...
Post
How much difference will Eli Lilly’s half-price insulin make?
When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. “It eats at me to know that taxpayer money is being wasted,” said Gilmer, who has Medicare and was diagnosed with Type 1 diabetes while a sophomore at the University of Colorado in 2002. The diagnosis...